product_135

CLBPEC Transfection Reagent (Neuroblastoma Cells)

$215.00$1,332.00

Kit Size VolumePriceAdd to Cart
0.5 ml (Catalog #1735)$215.00
1.5 ml (Catalog #1736)$444.00
8.0 ml (Catalog #1737)$1,332.00
SKU: CLBPEC

Product Description

NOTE: To place order using Credit Card, P-Card, or Purchase Order – please choose kit size above and click “Add to cart” button. You can place order online without creating an account.

Transfection Reagent for CLBPEC Cells (Neuroblastoma Cells)

  • Proprietary cationic lipids formulation
  • High transfection efficiency of small RNA (siRNA, shRNA, miRNA), mRNA, pDNA
  • Effective and robust intracellular delivery
  • Kit includes Transfection Enhancer reagent
  • A proven reagent for establishing stable cell lines
  • Download in vitro CLBPEC transfection protocol: [PDF]
  • Download PowerPoint presentation for CLBPEC cells transfection kit: [PPT]
  • Developed and manufactured by Altogen Biosystems

Transfection Efficiency:

Reagent exhibits at least 70% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.

Transfection Protocol and MSDS:

Download Altogen Biosystems Transfection Protocol: [PDF]

Download MSDS: [PDF]

CLBPEC Cell Line:

The CLBPEC cell line was derived and established from human neuroblastoma cells, which were removed from a patient who suffered from neuroblastoma (brain cancer). These cells are widely used in the study of cancers that affect young children. These cells make for a suitable transfection hosts, and biomedical research applications utilize CLBPEC cell lines.

Data:

CLBPEC Transfection Kit

Figure 1. GAPD mRNA levels were quantified using real-time RT-PCR in the CLBPEC cells transfected with siRNAs targeting GAPD or non-silencing siRNA. Forty-eight hours post-transfection, the cells were harvested and analyzed by real-time RT-PCR for GAPD mRNA expression levels. Data were normalized against the 18S rRNA signal. Control samples were either mock-transfected or untreated. Values are normalized to untreated sample. Data are means ± SD (n=5).

CLBPEC-cells-transfection-protocol

Figure 2. Protein expression of GAPDH in CLBPEC cells. DNA plasmid expressing GAPDH or siRNA targeting GAPDH were transfected into CLBPEC cells following Altogen Biosystems transfection protocol. At 72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control.

Altogen Biosystems:

Altogen Biosystems provides pre-optimized transfection kits and electroporation products for life sciences and cancer research. Transfection protocols are optimized for individual cancer cell lines. Altogen Biosystems developed two types of in vivo delivery kits (animal transfection): 1) Tissue-targeted reagents (delivery of proteins, DNA, and RNA into liver, pancreas, or kidney tissues), and 2) Broad range in vivo biodistribution reagents (PEG-Liposome based reagent, Nanoparticle-based in vivo reagent, Lipid-based transfection kit, and Polymer-based kit). Advanced formulation of reagents and optimized transfection protocols provide efficient intracellular delivery of proteins, DNA, mRNA, shRNA, siRNA, and other negatively charged biomolecules in  vitro and in vivo. Read more about transfection technology at Altogen’s Transfection Resource.

Altogen Research Services:

Altogen Labs provides GLP-compliant contract research studies for pre-clinical research, IND applications, and drug development. Biology CRO services include: Xenograft models (30+), development of stable cell lines, ELISA assay development, cell-based and tissue targeted RNAi studies, safety pharm/tox assays, and other studies (visit AltogenLabs.com).

Volume Options:

  • 0.5 ml (Catalog #1735)
  • 1.5 ml (Catalog #1736)
  • 8.0 ml (Catalog #1737)

Additional Information

Kit Size (Volume)

0.5 ml (Catalog #1735), 1.5 ml (Catalog #1736), 8.0 ml (Catalog #1737)